	Label	Description
	G45395BF Compound (Entity type)	type="Composition" mass="2368.84091476" permass="2943.48256763" monosaccharides="12" is_motif="False...
	G01650EU Compound (Entity type)	type="Composition" mass="1890.66104015" permass="2367.19314253" monosaccharides="10" is_motif="False...
	G37399XV Compound (Entity type)	type="Composition" mass="1728.60821665" permass="2163.09336882" monosaccharides="9" is_motif="False"...
	CD4 HUMAN Protein (Entity type)	T-cell surface glycoprotein CD4 (precursor)
	p01730-1 325asn 325asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification

G45395BF

type="Composition" mass="2368.84091476" permass="2943.48256763" monosaccharides="12" is_motif="False...

G01650EU

type="Composition" mass="1890.66104015" permass="2367.19314253" monosaccharides="10" is_motif="False...

G37399XV

type="Composition" mass="1728.60821665" permass="2163.09336882" monosaccharides="9" is_motif="False"...

CD4 HUMAN

T-cell surface glycoprotein CD4 (precursor)

p01730-1 325asn 325asn defined go:0006486 go:0006487

A Post Translational Modification

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.